EUCTR2015-001284-40-DK进行中（未招募）1 期
The effect of liraglutide on bone turnover, bone mass and bone cell function
Aarhus University Hospital0 个研究点目标入组 60 人开始时间: 2015年3月24日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Informed consent
- •Diagnosis of type 2 diabetes (HbA1c higher than 48 mmol/mol)
- •Postmenopausal (2 years since last menstrual bleeding)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Type 1 diabetes
- •Treatment with insulin
- •Body weight higher than 140 kg
- •Treatment with GLP-1 analogues, DPP-4 inhibitors, or glitazones
- •Chronic kidney disease
- •Hepatic disease
- •Pancreatitis
- •Inflammatory bowel disease
- •Osteoporosis
- •Family or personal history of medullary thyroid carcinoma
- •Treatment with glucocorticoids
- •Hormone replacement therapy
- •Diabetic gastroparesis
研究者
相似试验
已完成
4 期
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell FunctionDiabetes ComplicationsOsteoporosisNCT02473809University of Aarhus60
招募中
1 期
The effect of oral Semaglutide on bone turnover in patients with T2D: a randomized placebo-controlled clinical trial (SOBER II)Type 2 diabetesCTIS2023-505959-45-00Odense University Hospital64
进行中（未招募）
2 期
The Effect of Oral Semaglutide on Bone Turnover in Patients With T2D: a Randomized Placebo-controlled Clinical TrialOsteopeniaType 2 DiabetesNCT06050577Odense University Hospital64
Unknown
1 期
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone FractureOsteopeniaNCT04702516Morten Frost64
招募中
不适用
Clinical investigation of change of bone-related marker between denosumab and zoledronic acid in patients with treatment-naive,bone-metastasis prostate cancer:prospective, multiinstitutional,cohort studytreatment-naive prostate cancer with bone metastasisJPRN-UMIN000018268Department of Renal and Urologic Surgery, Asahikawa Medical University50